Promethos Capital’s Cardinal Health CAH Stock Holding History

Promethos Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.47M	Sell	18,819 -18,248	-49%	-$3.79M	1.22%	20
2026 Q1	$7.83M	Sell	37,067 -2,500	-6%	-$538K	2.1%	16
2025 Q4	$8.13M	Sell	39,567 -4,153	-9%	-$782K	2.22%	16
2025 Q3	$6.83M	Buy	43,720 +14,800	+51%	+$2.29M	1.83%	19
2025 Q2	$4.86M	Hold	28,920	–	–	1.64%	23
2025 Q1	$3.98M	Sell	28,920 -760	-3%	-$96.9K	1.46%	29
2024 Q4	$3.51M	Buy	29,680 +1,000	+3%	+$117K	1.24%	33
2024 Q3	$3.17M	Hold	28,680	–	–	1.13%	36
2024 Q2	$2.82M	Buy	28,680 +27,708	+2,851%	+$2.82M	1.07%	35
2024 Q1	$109K	Hold	972	–	–	0.06%	45
2023 Q4	$98K	Buy	+972	New	+$96.4K	0.07%	43

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Promethos Capital's CAH Position: Q2 2026 in Review

Promethos Capital reduced its Cardinal Health (CAH) stake by 49% in Q2 2026, selling an estimated $3.79M and leaving 18,819 shares worth $4.47M. The position accounts for 1.22% of the portfolio, ranked #20.

Promethos Capital first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.13M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Promethos Capital held 18,819 shares of Cardinal Health worth $4.47M as of Q2 2026.
Promethos Capital sold 18,248 Cardinal Health shares in Q2 2026, an estimated $3.79M.
Cardinal Health made up 1.22% of Promethos Capital's portfolio in Q2 2026, its #20 holding.
Promethos Capital first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
Promethos Capital's Cardinal Health position peaked at $8.13M in Q4 2025.
1,487 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Promethos Capital's 13F filing for Q2 2026, filed 12 Aug 2026.